M.L.A. also thanks MK 3-deazaneplanocin A cost Laboratories for providing writing services and data analysis on behalf of Triarco Industries. References 1. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M: The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci 2012, 67(11):1140–1152.PubMedCentralPubMedCrossRef 2. Chen J, Kim J, Dalton JT: Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv 2005, 5(3):173–188.PubMedCentralPubMedCrossRef 3. Moverare-Skrtic S, Venken K, Andersson N, Lindberg MK, Svensson J, Swanson C, Vanderschueren D, Oscarsson J, Gustafsson JA, Ohlsson
C: Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring) 2006, 14(4):662–672.CrossRef 4. Wang C, Swerdloff RS: Should the nonaromatizable Bafilomycin A1 purchase androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? J Clin Endocrinol Metab 2002, 87(4):1462–1466.PubMedCrossRef 5. Hong BS, Ahn TY: Recent trends in the treatment of testosterone deficiency syndrome. Int J Urol 2007, 14(11):981–985.PubMedCrossRef 6. Smith A: Sarcopenia, malnutrition and nutrient density in older people. Post Reprod Health 2014, 20(1):19–21.PubMedCrossRef 7. Buvat
J, Maggi M, Guay A, Torres LO: Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex
Med 2013, check details 10(1):245–284.PubMedCrossRef 8. Traish AM: 5alpha-Reductases in human physiology: an unfolding story. Endocr Pract 2012, 18(6):965–975.PubMedCrossRef 9. Bassil N, Alkaade S, Morley JE: The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 2009, 5(3):427–448.PubMedCentralPubMed 10. Issa SA, Dagres E: Intraoperative floppy-iris syndrome and finasteride intake. J Cataract Refract Surg 2007, 33(12):2142–2143.PubMedCrossRef 11. Modlinski R, Fields KB: The effect of anabolic steroids on the 4-Aminobutyrate aminotransferase gastrointestinal system, kidneys, and adrenal glands. Curr Sports Med Rep 2006, 5(2):104–109.PubMedCrossRef 12. Rahimi-Ardabili B, Pourandarjani R, Habibollahi P, Mualeki A: Finasteride induced depression: a prospective study. BMC Clin Pharmacol 2006, 6:7. BMC Clin Pharmacol 2006, 6:7.PubMedCentralPubMedCrossRef 13. Velazquez I, Alter BP: Androgens and liver tumors: Fanconi’s anemia and non-Fanconi’s conditions. Am J Hematol 2004, 77(3):257–267.PubMedCrossRef 14. Wong AC, Mak ST: Finasteride-associated cataract and intraoperative floppy-iris syndrome. J Cataract Refract Surg 2011, 37(7):1351–1354.PubMedCrossRef 15. Birzniece V, Sutanto S, Ho KK: Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators. J Clin Endocrinol Metab 2012, 97(4):E521–E527.PubMedCrossRef 16. Osterberg EC, Bernie AM, Ramasamy R: Risks of testosterone replacement therapy in men.